Andere Sprachen GENinCode Plc

Aktien

A3C31Y

GB00BL97B504

GENI

Markt geschlossen - London S.E. Andere Börsenplätze 17:35:16 14.06.2024			% 5 Tage	% 1. Jan.
7,125 ^GBX	0,00 %		+11,76 %	+35,71 %

04.06.	Transcript : GENinCode Plc, 2023 Earnings Call, Jun 04, 2024
03.06.	GENinCode steigert Umsatz durch fortgesetzte internationale Expansion	AN

Andere Sprachen

Schalten Sie alle Nachrichten frei: Seien Sie als Erster informiert und reagieren Sie vor den Märkten!

100% kostenlose Registrierung

GENinCode revenue grows amid continued international expansion	03.06.
FTSE 100 to be up before manufacturing data	03.06.
GENinCode Plc Reports Earnings Results for the Full Year Ended December 31, 2023	03.06.
GENinCode Plc Announces Publication by the American Journal of Preventive Cardiology of A Study on 'Polygenic Risk and Incident Heart Disease in a Large Multiethnic Cohort	04.04.
GENinCode says ROCA recommended as ovarian cancer risk test in England	21.03.
GENinCode gets GBP57,000 in retail offer, well below maximum	28.12.
GENinCode Raises GBP4 Million from Share Sale	28.12.
GENinCode raises GBP4 million via placing and subscription	21.12.
Genincode Plc Announces Placing And Subscription To Raise A Minimum Of £4.0 Mln	21.12.
Aura eyes Tiris expansion; Kavango backs Pambili	29.11.
GENinCode plc Agrees with the Food and Drug Administration to Create New Regulatory Class for Polygenic Risk scores and Transition Its Premarket Notification 510(K) Submission to A De Novo Pathway	29.11.
EARNINGS: ASA interim profit plummets; Mycelx loss narrows, revenue up	20.09.23
Earnings Flash (GENI.L) GENINCODE Reports H1 Revenue GBP950,000	20.09.23
Earnings Flash (GENI.L) GENINCODE Posts H1 Loss GBX-3.33	20.09.23
GENinCode Plc Provides Revenue Guidance for the Second Half of 2023	20.09.23
GENinCode Plc Reports Earnings Results for the Half Year Ended June 30, 2023	20.09.23
Genincode plc Announces CARDIO inCode study on risk of incident Coronary Heart Disease	30.08.23
GENinCode Shares Rise on FDA Filing for Heart Disease Test Kit	16.08.23
GENinCode Submits Premarket Notification for US Commercial Distribution of Polygenic Test Kit	16.08.23
GENinCode plc Files its Premarket Notification with the Food and Drug Administration to Expand Its US Commercial Distribution of the Cardio InCode-Score Polygenic Test for the Risk Assessment and Prevention of Coronary Heart Disease	16.08.23

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen GENinCode Plc

Aktien

A3C31Y

GB00BL97B504

GENI

Andere Sprachen

Filter